Windtree Therapeutics News - WINT

Company Name	Stock Ticker Symbol	Market	Type
Windtree Therapeutics Inc	WINT	NASDAQ	Common Stock

	Price Change	Change Percent	Stock Price	Last Traded
	0.3398	6.23%	5.7898	11:14:33

Open Price	Low Price	High Price	Close Price	Prev Close
5.38	5.00	5.90		5.45

more quote information »

Recent News

Date	Time	Source	Heading
4/18/2024	08:00	GLOBE	Windtree Therapeutics Announces Reverse Stock Split
4/17/2024	08:00	GLOBE	Windtree Therapeutics Reports Fourth Quarter and Year-End..
4/08/2024	16:48	GLOBE	Windtree Acquires Early-Stage, Novel Oncology Platform and..
2/16/2024	17:07	EDGAR2	Form 8-K - Current report
2/14/2024	17:23	EDGAR2	Form S-3 - Registration statement under Securities Act of..
2/14/2024	16:30	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/13/2024	20:15	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2/12/2024	16:40	EDGAR2	Form PRE 14A - Other preliminary proxy statements
2/01/2024	17:26	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2/01/2024	08:00	GLOBE	Windtree Renews Agreement with Chang Gung University for..
1/31/2024	08:40	IHNW	Windtree Therapeutics Announces Engagement of Strategic..
1/31/2024	08:00	EDGAR2	Form 8-K - Current report
1/31/2024	08:00	GLOBE	Windtree Therapeutics Announces Engagement of Strategic..
1/25/2024	09:04	IHNW	Windtree Eliminates $15 Million Contingent Liability to..
1/25/2024	08:34	EDGAR2	Form 8-K - Current report
1/25/2024	08:30	GLOBE	Windtree Eliminates $15 Million Contingent Liability to..
1/22/2024	16:45	EDGAR2	Form 8-K - Current report
1/17/2024	08:00	GLOBE	Windtree Therapeutics Announces License Agreement with Lee’s..
1/17/2024	07:56	EDGAR2	Form 8-K - Current report
1/16/2024	16:16	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
1/02/2024	16:05	GLOBE	Windtree Therapeutics Announces Reduction In Arrythmias In A..
12/18/2023	08:00	GLOBE	Windtree Therapeutics Announces the Start of Patient Dosing..
11/16/2023	08:00	GLOBE	Windtree Therapeutics Announces Issuance of New Pure SERCA2a..
11/13/2023	11:41	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
11/09/2023	16:21	EDGAR2	Form 8-K - Current report
11/09/2023	16:15	GLOBE	Windtree Therapeutics Reports Third Quarter 2023 Financial..
11/09/2023	16:11	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
11/09/2023	16:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/08/2023	08:00	GLOBE	Windtree to Present at the Sidoti Micro Cap Conference on..
10/12/2023	07:30	GLOBE	Windtree to Present at the ThinkEquity Conference on October..
10/10/2023	07:30	GLOBE	Windtree to Participate in the Lytham Partners Fall 2023..
10/03/2023	08:00	GLOBE	Windtree to Present at the Dawson James Small Cap Growth..
9/28/2023	07:24	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/27/2023	07:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
9/26/2023	08:48	EDGAR2	Form 8-K - Current report
9/21/2023	09:35	GLOBE	Dawson James Securities Announces October Date for 8th..
9/05/2023	19:21	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
8/30/2023	16:31	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
8/29/2023	16:37	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/28/2023	16:15	EDGAR2	Form 8-K - Current report
8/25/2023	18:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	18:03	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	18:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	18:01	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	18:00	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/25/2023	17:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
8/23/2023	08:00	GLOBE	Windtree Announces Issuance of Composition of Matter Patent..
8/16/2023	17:19	EDGAR2	Form 8-K - Current report
8/07/2023	16:05	GLOBE	Windtree Therapeutics Reports Second Quarter 2023 Financial..
8/07/2023	16:02	EDGAR2	Form 8-K - Current report